Εμφάνιση απλής εγγραφής

dc.creatorLiakopoulos V., Nikitidou O., Kalathas T., Roumeliotis S., Salmas M., Eleftheriadis T.en
dc.date.accessioned2023-01-31T08:50:15Z
dc.date.available2023-01-31T08:50:15Z
dc.date.issued2017
dc.identifier10.1007/s11255-017-1632-9
dc.identifier.issn03011623
dc.identifier.urihttp://hdl.handle.net/11615/75808
dc.description.abstractIn 2016, the International Society of Peritoneal Dialysis (ISPD) published guidelines that focus on the importance of both prevention and treatment of peritonitis. For once more, the need for annual reporting of peritonitis rates and recording of peritonitis and exit-site infections, isolated microorganism and antimicrobial susceptibilities as a central component of a quality improvement program is highlighted. Data on new antibiotic regimens, techniques for microorganism isolation and peritoneal dialysis solutions are included. Training of both peritoneal dialysis nurses and patients seems to be crucial, while the modifiable risk factors for peritonitis seem to be of great interest. In this article, we record the changes in the last ISPD (2016) guidelines compared to the previous ones published in 2010. © 2017, Springer Science+Business Media Dordrecht.en
dc.language.isoenen
dc.sourceInternational Urology and Nephrologyen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85020123656&doi=10.1007%2fs11255-017-1632-9&partnerID=40&md5=3566560c71730804594468d579933ceb
dc.subjectaminoglycoside antibiotic agenten
dc.subjectcephalosporin derivativeen
dc.subjectciprofloxacinen
dc.subjectfluconazoleen
dc.subjectgentamicinen
dc.subjectnystatinen
dc.subjectpseudomonic aciden
dc.subjectrifampicinen
dc.subjectantifungal agenten
dc.subjectantiinfective agenten
dc.subjectantibiotic prophylaxisen
dc.subjectautomationen
dc.subjectbacterium cultureen
dc.subjectcatheter removalen
dc.subjectcatheterizationen
dc.subjectcontinuous ambulatory peritoneal dialysisen
dc.subjectGram negative infectionen
dc.subjectGram positive infectionen
dc.subjecthealth programen
dc.subjecthumanen
dc.subjectinfection risken
dc.subjectmedical societyen
dc.subjectmycosisen
dc.subjectnon tuberculous mycobacterial peritonitisen
dc.subjectnonhumanen
dc.subjectperitoneal dialysisen
dc.subjectperitonitisen
dc.subjectpractice guidelineen
dc.subjectprognosisen
dc.subjectReviewen
dc.subjectrisk factoren
dc.subjectStaphylococcus aureusen
dc.subjectStaphylococcus infectionen
dc.subjecttuberculous peritonitisen
dc.subjectcomplicationen
dc.subjectGram negative infectionen
dc.subjectGram positive infectionen
dc.subjectmicrobiologyen
dc.subjectmixed infectionen
dc.subjectmycosisen
dc.subjectperitoneal dialysisen
dc.subjectperitonitisen
dc.subjectpractice guidelineen
dc.subjectAnti-Bacterial Agentsen
dc.subjectAntifungal Agentsen
dc.subjectCoinfectionen
dc.subjectGram-Negative Bacterial Infectionsen
dc.subjectGram-Positive Bacterial Infectionsen
dc.subjectHumansen
dc.subjectMycosesen
dc.subjectPeritoneal Dialysisen
dc.subjectPeritonitisen
dc.subjectPractice Guidelines as Topicen
dc.subjectSpringer Netherlandsen
dc.titlePeritoneal dialysis-related infections recommendations: 2016 update. What is new?en
dc.typeotheren


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής